Sectoral Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Sectoral Asset Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,991	Closed	-$19K	–	93
2019 Q2	$19K	Hold	1,991	–	–	﹤0.01%	92
2019 Q1	$53K	Hold	1,991	–	–	0.01%	104
2018 Q4	$45K	Hold	1,991	–	–	0.01%	102
2018 Q3	$110K	Buy	+1,991	New	+$127K	0.01%	158
2015 Q4	–	Sell	-34,602	Closed	-$5.16M	–	81
2015 Q3	$5.16M	Sell	34,602 -10,052	-23%	-$7.38M	0.24%	53
2015 Q2	$42.4M	Buy	44,654 +14,384	+48%	+$11.8M	1.77%	18
2015 Q1	$22.2M	Buy	+30,270	New	+$22.7M	0.84%	39

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Sectoral Asset Management's TTPH Position: Q3 2019 in Review

Sectoral Asset Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 1,991 shares — an estimated $19K sold.

Sectoral Asset Management first reported a position in TTPH in Q1 2015 and held it in 7 quarters. The position peaked at $42.4M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

Sectoral Asset Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Sectoral Asset Management sold 1,991 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $19K.
Sectoral Asset Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
Sectoral Asset Management's Tetraphase Pharmaceuticals, Inc. position peaked at $42.4M in Q2 2015.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.